DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 15 filers reported holding DIREXION SHS ETF TR in Q4 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70 | +125.8% | 799 | +189.5% | 0.00% | – |
Q4 2022 | $31 | -100.0% | 276 | -86.0% | 0.00% | – |
Q1 2022 | $257,000 | +26.6% | 1,971 | +40.5% | 0.00% | – |
Q4 2021 | $203,000 | -17.5% | 1,403 | -38.9% | 0.00% | – |
Q3 2021 | $246,000 | +2.5% | 2,296 | 0.0% | 0.00% | – |
Q2 2021 | $240,000 | +140.0% | 2,296 | +90.9% | 0.00% | – |
Q1 2021 | $100,000 | +1.0% | 1,203 | -7.0% | 0.00% | – |
Q4 2020 | $99,000 | -12.4% | 1,293 | -15.7% | 0.00% | – |
Q4 2019 | $113,000 | +145.7% | 1,534 | +57.5% | 0.00% | – |
Q4 2018 | $46,000 | -81.0% | 974 | -73.3% | 0.00% | -100.0% |
Q3 2018 | $242,000 | +2320.0% | 3,646 | +1419.2% | 0.00% | – |
Q2 2018 | $10,000 | +100.0% | 240 | +14.8% | 0.00% | – |
Q4 2016 | $5,000 | -66.7% | 209 | -55.6% | 0.00% | -100.0% |
Q3 2016 | $15,000 | -85.8% | 471 | -86.0% | 0.00% | -85.7% |
Q2 2016 | $106,000 | +960.0% | 3,363 | +780.4% | 0.01% | +600.0% |
Q1 2016 | $10,000 | -93.8% | 382 | -90.7% | 0.00% | -92.3% |
Q2 2015 | $161,000 | +3120.0% | 4,112 | +10721.1% | 0.01% | +1200.0% |
Q4 2014 | $5,000 | – | 38 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tower Research Capital LLC (TRC) | 55,597 | $2,523,000 | 0.14% |
Traynor Capital Management, Inc. | 7,481 | $341,000 | 0.12% |
Virtu Financial LLC | 49,149 | $2,230,000 | 0.10% |
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 2,436 | $111,000 | 0.08% |
Capital Analysts, LLC | 6,000 | $272,000 | 0.03% |
Acorn Wealth Advisors, LLC | 395 | $18,000 | 0.02% |
BANQUE PICTET & CIE SA | 10,120 | $459,000 | 0.01% |
Citadel Advisors | 78,471 | $3,560,000 | 0.00% |
WOLVERINE TRADING, LLC | 22,300 | $960,000 | 0.00% |
JANE STREET GROUP, LLC | 21,346 | $968,000 | 0.00% |